Renal Cancers Terminated Phase 2 Trials for Naltrexone (DB00704)

Also known as: Renal Cancer / Kidney Cancer / Renal malignant neoplasm / Renal neoplasms malignant / Cancer of Kidney

IndicationStatusPhase
DBCOND0044624 (Renal Cancers)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01650350Low Dose Naltrexone for Metastatic Melanoma, Castrate Resistant Prostate Cancer and Renal CancerTreatment